IOL Chemicals and Pharmaceuticals Limited Holds 39th AGM, Approves Financials and Director Reappointment
IOL Chemicals and Pharmaceuticals Limited conducted its 39th AGM on September 2, 2026. Key resolutions passed included adopting the FY26 financial statements and reappointing Mr. Kushal Kumar Rana as director. The remuneration of the Cost Auditor for FY27 was also ratified.
The AGM's outcomes, including the approval of financial statements and director reappointments, are routine but important for corporate governance and investor confidence.
The announcement details the successful completion of the AGM with all resolutions passed, indicating positive corporate governance and shareholder engagement.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) held its 39th Annual General Meeting (AGM) on Wednesday, 2nd September 2026, commencing at 11:30 a.m. through Video Conferencing/Other Audio-Visual Means (VC/OAVM).
The meeting focused on the adoption of the standalone and consolidated audited financial statements for the financial year ended 31st March 2026, along with the reports of the Board of Directors and Auditors. Shareholders also voted on the reappointment of Mr. Kushal Kumar Rana as a director, who retires by rotation. Additionally, the remuneration of the Cost Auditor for the financial year ending 31st March 2027 was ratified.
All three ordinary resolutions presented at the AGM were passed with a significant majority. The voting results, along with the Scrutinizer's Report, were submitted to the National Stock Exchange of India Ltd. and BSE Limited as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.